ABCC1 and non-small cell lung carcinoma: In locally advanced NSCLC, patients with high MRP1 level had a worse histopathologic response to cisplatin-based chemotherapy, and a shorter tumor-free survival and overall survival than those with low MRP1 expression (Sedoris et al., 2010).